Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE · IEX Real-Time Price · USD
4.840
-0.030 (-0.62%)
At close: Apr 22, 2024, 4:00 PM
4.740
-0.100 (-2.07%)
After-hours: Apr 22, 2024, 5:00 PM EDT
Wave Life Sciences Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Wave Life Sciences stock have an average target of 12.5, with a low estimate of 5.00 and a high estimate of 19. The average target predicts an increase of 158.26% from the current stock price of 4.84.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for WVE stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Hold | 2 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Reiterates $17 | Strong Buy | Reiterates | $17 | +251.24% | Apr 1, 2024 |
| Mizuho | Mizuho | Strong Buy Maintains $10 → $19 | Strong Buy | Maintains | $10 → $19 | +292.56% | Mar 12, 2024 |
| RBC Capital | RBC Capital | Hold Reiterates $5 | Hold | Reiterates | $5 | +3.31% | Mar 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $8 → $15 | Strong Buy | Maintains | $8 → $15 | +209.92% | Mar 7, 2024 |
| Leerink Partners | Leerink Partners | Hold → Buy Upgrades $12 | Hold → Buy | Upgrades | $12 | +147.93% | Dec 19, 2023 |
Financial Forecast
Revenue This Year
77.14M
from 113.31M
Decreased by -31.92%
Revenue Next Year
53.36M
from 77.14M
Decreased by -30.83%
EPS This Year
-1.02
from -0.54
EPS Next Year
-1.08
from -1.02
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 105.0M | 103.3M | 160.6M | 201.3M | 270.9M |
| Avg | 77.1M | 53.4M | 88.3M | 108.0M | 162.9M |
| Low | 39.2M | 5.9M | 34.3M | 34.3M | 49.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -7.3% | 33.9% | 200.9% | 128.0% | 150.9% |
| Avg | -31.9% | -30.8% | 65.5% | 22.3% | 50.9% |
| Low | -65.4% | -92.4% | -35.7% | -61.1% | -54.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.66 | -0.91 | -0.42 | -0.01 | 0.36 |
| Avg | -1.02 | -1.08 | -0.88 | -0.34 | -0.19 |
| Low | -1.29 | -1.49 | -1.15 | -0.95 | -0.86 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.